MODIFICATION
65 -- Opportunistic Drugs and Home Base Care Drugs and Products Procurement
- Notice Date
- 8/18/2006
- Notice Type
- Modification
- NAICS
- 424210
— Drugs and Druggists' Sundries Merchant Wholesalers
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- Reference-Number-07252006
- Response Due
- 8/29/2006
- Point of Contact
- John Ebanks, Contract Specialist, Phone 7704882436, Fax 7704882688, - Andrea Roberson, Acquisition Logistics Specialist II, Phone 770-488-2655, Fax 770-488-2668,
- E-Mail Address
-
JEbanks@cdc.gov, fPI1@cdc.gov
- Description
- The purpose of this amendment is to incorporate answers to questions received from potential offerors regarding this solicitation, extend the closing date of the combined synopsis/solicitation, implement a closing date for questions and provide clarification as to how prices will be evaluated. Solicitation 200-2006-18431 is hereby amended as follows: ? Answers to questions received for this solicitation are hereby provided. (See below) ? As a result of changes being made in this amendment, the due date for proposals is hereby extended from 10:00 AM August 29, 2006 to 10:00 AM September 5, 2006. ? Inquiries concerning the solicitation document should be submitted in writing to the issuing office. Any additions, deletions, or changes to the solicitation will be made by an amendment. OFFERORS ARE INSTRUCTED SPECIFICALLY TO CONTACT ONLY THE SOLICITATION CONTRACTING OFFICE IN CONNECTION WITH ANY ASPECT OF THIS REQUIREMENT PRIOR TO CONTRACT AWARD. PROPOSALS AND ALL CORRESPONDENCE RELATING TO THE SOLICITATION DOCUMENT SHALL BE SUBMITTED TO THE CONTRACTING OFFICE. Inquiries should be received at the Contracting Office no later than Monday, August 21, 2006, and maybe submitted via e-mail to egz2@cdc.gov. ? Weighted average unit price method of evaluation will be utilized to evaluate price. Line items requesting range pricing will be determined utilizing the Weighted Average Unit Price method. Those with single numeric quantity will be determined by multiplying the quantity with the offeror?s proposed unit price. This means that a representative percentage will be calculated for each quantity of each drug. Please note that all percentages will be rounded to the whole percentage and the HIGHEST quantity for each option range will be utilized. For example, quantities of ****300, 600, and 900 equal a total quantity of 1,800. The percentage for each quantity is 17%, 33%, and 50% respectively (take each quantity divided by the total quantity). Then each percentage is multiplied by its respective proposed unit price. This represents each quantities weighted unit price. For example, if the unit prices were $5.00, $3.00, and $2.00, respectively, the weighted unit prices will be $.85, $.99, $1.00 respectively. Please note that all weighted unit prices will be rounded to the whole penny. The weighted unit price is then multiplied by its respective quantity rounded to the nearest dollar, to get the total price for each quantity. All prices for all line items will then be added together to determine the total overall evaluated price. This price will then be utilized to determine the offerors total evaluated price. ? Except as provided herein, all terms and conditions of the the combined synopsis/solicitation 200-2006-184231, remains unchanged and in full force and effect. Responses to Questions 1q. In the solicitation's first paragraph, it states that . . . "The product with the lowest cost, which can meet all of the specifications and quality requirement, is then procured." What are the quality requirements for the listed drugs? 1a. Drugs must be registered and approved for use in Vietnam. 2q. Does CDC have approved sources for the listed drugs? If so, please provide this list. 2a. No. 3q. Is it correct that offerors must meet the certification and storage requirements of the solicitation to be eligible for award? 3a. Yes. 4q. Having met the technical requirements, will the award of this contract go to the respondent with the lowest overall pricing, as provided in the OI/HBC Drug price List? 4a. Yes. 5q. Is it a requirement that the proposed pricing include all expenses associated with the delivery of these drugs throughout Vietnam? (For instance, all overhead charges, shipping charges, administrative charges, etc.) 5a. Absolutely. 6q. What medicines will be provided by PEPFAR? Are these at no cost to respondents? 6a. Drugs that are delivered untations do not follow the format of the attachment and include prices for all quantity ranges, the quotation will not be considered. IAW FAR 13.302-2 a realistic monetary limitation shall be placed on the total order. The monetary limitation shall be an obligation subject to adjustment when the firm price is established. The contracting officer or the contracting officer’s designated representative shall review the invoice price and, if reasonable (see FAR13.106-3(a)), process the invoice for payment. The following Federal Acquisition Regulation (FAR) clauses are applicable to this combined synopsis/solicitation: 52.212-1 - Instructions to Offerors – Commercial Items 52.212-3 – Offeror Representations and Certifications – Commercial Items 52.212-4 – Contract Terms and Conditions – Commercial Items 52.212-5 – Contract Terms and Conditions Required to Implement Statutes or Executive Orders * * The Request for Quotations for this solicitation along with all proof of certification requirements MUST be emailed by electronic mail to egz2@cdc.gov (FIRST PREFERENCE) OR (IF YOU ARE NOT ABLE TO EMAIL) by mail delivered to: Centers for Disease Control and Prevention (CDC), mail Stop, K75 Attn: John Ebanks, Contract Specialist, 2920 Brandywine Rd, Atlanta, GA 30341-5539. Responses via facsimile (FAX) WILL NOT be accepted. Point of Contact John Ebanks, Contract Specialist, Phone 770-488-2436, Fax 770-488-2688, Email egz2@cdc.gov. Charlene Allison, Contract Specialist, Phone 770-488-2841, Fax 770-488-2688, Email FKK1@CDC.GOV. Andrea Roberson, Acquisition Logistics Specialist II, Phone 770-488-2687, Fax 770-488-2688, Email fpi1@cdc.gov. * ALL QUOTATIONS RECEIVED BY THIS OFFICE AFTER THE CLOSING DATE AND TIME SPECIFIED SHALL BE DETERMINED TO BE LATE AND WILL NOT BE CONSIDERED FOR AWARD * Sample List of Drugs: Cotrimoxazole, Cotrimoxazole syrup, Fluconazole, Fluconazole suspension, Itraconazole, Acyclovir, Acyclovir solution, Dapsone, Trimethoprim, Trimethoprim solution, Clindamycin, Primaquine, Azithromycin, Amphotericin B, Multivitamin, Multivitamin syrup, Acetaminophen, Acetominophen syrup, Acetominophen syrup, Ibuprofen, Ibuprofen suspension, Loperamide, Metaclopramide, Metaclopramide, Metaclopramide liquid, Prochlorperazine, Prochlorperazine liquid, Prochlorperazine, Permethrin 5%, Lindane 1%, Gatifloxacin, Doxycycline, Ceftriaxone IM, Penicillin Benzathine - IM, Penicillin Benzathine - IM, Penicillin Procaine - IV, Ganciclovir, Valganciclovir, Acetominophen/Codeine, Salbutamol Nebulizers, Prednisolone, Promethazine, Promethazine Syrup, Mebendazole, Albendazole Syrup, DEP 30mg (bottles), Aspirin 325mg, Simethicone 80mg, Vitamin B compound, Oral Rehydration Salts (sachet), Calamine Lotion (bottle), Petrolium Jelly, Alcohol (Liter), Zinc Oxyde Talcum Powder, Medicated Balm, Hydrogen Peroxide 3% (100ml), Povidine Iodine (liter), Condom, Ciprofloxacin, Ketoconazole, Nystatin solution, Spiramycin, Amoxicillin, Clarythromycin, Zinnat, Ofloxacin, Cephalexin, Metronidazole, Negram, Nalicid, Erythromycin, Bristopen, L-bio (sachet), Berberine, Nospa 40 mg, Phosphalugel, Boganic, Peritol 4mg, Smecta, Maalox, Sorbitol, Alaxan, Loratidine, Cimetidine, Biosubtyl, Lecithin, Diclofenac 50 mg (Arthritis), Terpin codeine, Acemuc, Cough lozenges, Stugeron 250mg, Antibiotic ointment, Corticosteroids cream, Nizoral cream, Acyclovir ointment, Acne skin cream, Ercefuril, vitamine A solution, Vitamine C, Iron Pills (Ferimax), Iron with folate pills (Fefolic), Chlorpheniramin 4mg, Pyrimethamine, Acetylcysteine NOTE: THIS NOTICE MAY HAVE POSTED ON FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (18-AUG-2006). IT ACTUALLY APPEARED OR REAPPEARED ON THE FEDBIZOPPS SYSTEM ON 08-NOV-2006, BUT REAPPEARED IN THE FTP FEED FOR THIS POSTING DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.fbo.gov/spg/HHS/CDCP/PGOA/Reference-Number-07252006/listing.html)
- Place of Performance
- Address: Address: Hanoi
- Country: VIET NAM
- Country: VIET NAM
- Record
- SN01178745-F 20061110/061108223044 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |